Trial Profile
Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- 29 Jun 2010 Pharmacodynamic outcomes were reported at the 70th Annual Scientific Sessions of the American Diabetes Association.
- 01 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Oct 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.